(Reuters) – Sanofi (NASDAQ:SNY) has entered into discussions with U.S. private equity firm Clayton Dubilier & Rice to sell a controlling 50% stake in its consumer health business Opella, the French pharmaceutical giant said on Friday.
The announcement confirms an earlier Reuters report about the sale estimated at 15 billion euros ($16.41 billion).
Sanofi did not disclose any financial details of the potential deal and said further updates will be provided in due course.
($1 = 0.9143 euros)
This post appeared first on investing.com
